Previous Close | 104.85 |
Open | 104.95 |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's Range | 104.55 - 106.40 |
52 Week Range | 75.45 - 111.10 |
Volume | |
Avg. Volume | 458,443 |
Market Cap | 27.961B |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | -2.82 |
Earnings Date | N/A |
Forward Dividend & Yield | 2.50 (2.38%) |
Ex-Dividend Date | May 09, 2024 |
1y Target Est | 122.10 |
Key Insights DSM-Firmenich's estimated fair value is €119 based on 2 Stage Free Cash Flow to Equity With €101 share...
NEW YORK, April 04, 2024 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced DSM Firmenich AG (Euronext Amsterdam: DSFIR; OTCQX: DSFIY, DSMFF), a leading innovator in nutrition, health, and beauty, has qualified to trade on the OTCQX® Best Market. DSM Firmenich AG upgraded to OTCQX from the Pink® Limited market. DSM Firmenich AG begins trading today on OTCQX under the symbols “DSFIY and DSMF
Key Insights Significant control over DSM-Firmenich by retail investors implies that the general public has more power...